Effects of Repetitive Hyperbaric Oxygen Treatment in Patients with Acute Cerebral Infarction: A Pilot Study

Table 1

Baseline characteristics of the study participants.

	HBOT group (𝑛=16)	Controls (𝑛=30)	𝑃 value
Gender, male/female	13/3	15/15	0.550
Age (years)	68.375 (32–88)	68.867 (44–86)	0.896
Past history	1.75 (0–3)	1.7 (0–3)	0.930
Triglycerol (mg/dl)	137.375 (52–408)	165.138 (50–359)	0.602
T. cholesterol (mg/dl)	181.313 (116–290)	201.833 (122–282)	0.176
Homocysteine (μmol/L)	11.54 (4.78–16.36)	11.27 (3.10–20.45)	0.122
Clinical characteristics
Risk factor, yes/no	3/13	14/16	0.569
Aspirin, yes/no	12/4	25/5	0.698
Anticoagulant, yes/no	4/12	9/21	0.245
Piracetam, yes/no	11/5	13/17	0.100
Antilipid agents, yes/no	4/12	10/20	0.063
Antihypertensives, yes/no	13/3	25/5	0.100
Oral antidiabetics, yes/no	7/9	11/19	0.100
Rehabilitation, yes/no	12/4	21/7	0.516